Latest news with #U.S.SecuritiesExchangeActof1934
Business Wire
14-07-2025
- Business
- Business Wire
Cognyte Announces Board Authorization of New $20 Million Share Repurchase Program
HERZLIYA, Israel--(BUSINESS WIRE)-- Cognyte Software Ltd. (NASDAQ: CGNT), a global leader in software-driven technology for investigative analytics, today announced that its board of directors has approved a new share repurchase program. The company completed the repurchase program previously authorized by the board and repurchased a total of 2,094,538 ordinary shares for an aggregate purchase price of $20 million. The new program announced today authorizes the buyback of up to an additional $20 million in ordinary shares over the next 18 months through January 14, 2027, as part of the Company's capital allocation strategy. The board and management remain committed to delivering value to shareholders and are confident in the Company's growth prospects and ability to generate cash. The Company may repurchase its ordinary shares from time to time through open market purchases, privately negotiated transactions or otherwise, all in accordance with U.S. securities laws and regulations, including Rule 10b-18 under the U.S. Securities Exchange Act of 1934, as amended. The Company may also, from time to time, enter into plans that are compliant with Rule 10b5-1 of the Exchange Act to facilitate repurchases of its shares under this authorization. The repurchase program does not obligate the Company to acquire any particular number of ordinary shares, and the repurchase program may be suspended or discontinued at any time at the Company's discretion. Repurchases under the repurchase program may begin after the conclusion of a 30-day period for creditors of the Company to object to the Company's intent to effect a deemed distribution by way of repurchase in accordance with the Israeli Companies Regulations (Relief for Public Companies Whose Securities are Traded on Stock Exchanges Outside of Israel), 5760-2000 and the Israeli Companies Regulations (Approval of Distribution), 5761–2001. The timing, number and value of shares to be repurchased will depend on the market price of the Company's ordinary shares, general market and economic conditions, and other factors. The Company expects to fund repurchases with cash on its balance sheet and ongoing cash flow generation. Any shares acquired will be available for general corporate purposes. About Cognyte Cognyte is a leading software-driven technology company, focused on solutions for data processing and investigative analytics that allow customers to generate Actionable Intelligence for a Safer World™. Cognyte's solutions empower law enforcement, national security, national and military intelligence agencies, and other organizations to navigate an increasingly complex threat landscape. With offerings that leverage state-of-the-art technology, including Artificial Intelligence (AI), big data analytics and advanced machine learning, Cognyte helps customers make smarter, faster decisions with their data for the best possible outcomes. Hundreds of customers rely on Cognyte's investigative analytics solutions to uncover critical insights from past events and anticipate emerging threats. By harnessing AI-driven intelligence, Cognyte accelerates investigations with exceptional speed and accuracy while enabling customers to better investigate, anticipate, predict and mitigate risks with greater precision. Learn more at Cautionary Statement Regarding Forward-Looking Statements Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements are identified by use of the words 'anticipates,' 'believes,' 'estimates,' 'expects,' 'intends,' 'plans,' 'predicts,' 'projects,' 'should,' 'views,' and similar expressions. Any forward-looking statements contained herein are based on current expectations, but are subject to risks and uncertainties that could cause actual results to differ materially from those indicated, including, but not limited to the projected growth of Cognyte's business, and Cognyte's ability to achieve its financial and business plans, goals and objectives and drive shareholder value, including with respect to its ability to successfully implement its strategy, and other risk factors discussed from time to time in Cognyte's filings with the SEC, including those factors discussed under the caption 'Risk Factors' in its most recent annual report on Form 20-F, filed with the Securities and Exchange Commission ('SEC') on April 2, 2025, and in subsequent reports filed with or furnished to the SEC. Cognyte assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today's date.
Yahoo
17-06-2025
- Business
- Yahoo
VEON Appoints Vitaly Shmakov as Acting General Counsel
Dubai, June 17, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator ('VEON' or the 'Company'), is pleased to announce that it has appointed Vitaly Shmakov as the Acting General Counsel, based in VEON's headquarters in the Dubai International Financial Center, effective July 1, 2025. Vitaly Shmakov is currently serving as Group Director of M&A and Strategic Transactions at VEON. Since joining the Company in 2016, he has held various roles, including Deputy General Counsel for Corporate, M&A and Strategic Transactions; Associate General Counsel; and Senior Legal Counsel. Prior to joining VEON, Vitaly was a Senior Associate for M&A and Corporate Law at Ashurst LLP, an international law firm based in London. He holds an LL.M in International Business and Trade Law from the NYU School of Law, an LL.M in Corporate & Financial Services from the National University of Singapore and is currently enrolled in an Executive MBA with the London Business School. 'With a career spanning nearly 20 years in M&A and corporate law, Vitaly is a great candidate to lead our stellar legal team as our Acting General Counsel. This appointment demonstrates the success of our talent strategy: we not only transform our business for accelerated growth, but we also grow our talent to meet the evolving needs of the Company. We will continue working with the VEON Leadership Team including Vitaly to successfully execute our transformative initiatives, including progressing with our plans to list Kyivstar on Nasdaq Stock Market,' said Augie K Fabela II, Chairman of VEON Board and VEON Founder. 'Vitaly has played a leadership role in many of the M&A transactions that have shaped VEON into the company it is today. With his expertise in corporate development and corporate law, and with nearly ten years of experience in VEON during which he worked with many cross-functional teams to deliver strategic projects, I am confident that Vitaly will make a strong contribution to VEON's continued success in his new capacity as our Acting General Counsel,' said Kaan Terzioglu, VEON Group CEO. About VEONVEON is a digital operator that provides connectivity and digital services to nearly 160 million customers. Operating across six countries that are home to more than 7% of the world's population, VEON is transforming lives through technology-driven services that empower individuals and drive economic growth. VEON is listed on NASDAQ and headquartered in Dubai. For more information visit: DisclaimerThis release contains 'forward-looking statements,' as the phrase is defined in Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Forward-looking statements are not historical facts, and are inherently subject to risks and uncertainties, many of which VEON cannot predict with accuracy and some of which VEON might not anticipate. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements relating to, among other things, the execution of VEON's strategy and the planned listing of Kyivstar on Nasdaq Stock Market. The forward-looking statements contained in this release speak only as of the date of this release. VEON does not undertake to publicly update, except as required by U.S. federal securities laws, any forward-looking statement to reflect events or circumstances after such dates or to reflect the occurrence of unanticipated events. Contact Information Communications pr@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10-06-2025
- Business
- Yahoo
Aspen Prices Public Offering of US$300,000,000 of Senior Notes
HAMILTON, Bermuda, June 10, 2025--(BUSINESS WIRE)--Aspen Insurance Holdings Limited ("Aspen" or the "Company") (NYSE: AHL) has priced an underwritten public offering of US$300,000,000 aggregate principal amount of 5.750% senior notes due 2030 (the "Notes"). The Notes were priced at 99.870% of the principal amount and will mature on July 1, 2030. The offering was made pursuant to an effective shelf registration statement and is expected to close on June 13, 2025, subject to the satisfaction of customary closing conditions. Aspen intends to use the net proceeds from the offering, together with cash on hand, to repay the indebtedness outstanding under its term loan credit agreement. The offering was led by Citigroup Global Markets Inc., HSBC Securities (USA) Inc. and Lloyds Securities Inc., as joint book-running managers. This offering may be made only by means of a preliminary prospectus supplement and accompanying prospectus. Copies of the final prospectus and accompanying prospectus may be obtained, when available, from the U.S. Securities and Exchange Commission's website at Alternatively, these documents are available from the underwriters by contacting any of the following: Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by calling: (800) 831-9146 or by emailing prospectus@ HSBC Securities (USA) Inc., 66 Hudson Boulevard, New York, NY 10001, Attention: Debt Capital Markets or by calling (866) 811-8049; or Lloyds Securities Inc., 1095 Avenue of the Americas, 34th Floor, New York, New York 10036, by calling (212) 930-5039, or by emailing NALSIBondSyndicate@ This press release shall not constitute an offer to sell or a solicitation of an offer to buy the Notes, nor shall there be any sale of the Notes in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Aspen Insurance Holdings Limited Aspen provides insurance and reinsurance coverage to clients in various domestic and global markets through wholly-owned operating subsidiaries in Bermuda, the United States and the United Kingdom, as well as its branch operations in Canada, Singapore and Switzerland. Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, which include, but are not limited to, statements related to the Company's expectations regarding the use of the net proceeds from the offering, and are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts. In particular, statements that use the words such as "believe," "anticipate," "expect," "assume," "objective," "target," "plan," "estimate," "project," "seek," "will," "may," "aim," "likely," "continue," "intend," "guidance," "outlook," "trends," "future," "could," "would," "should," "target," "predict," "potential," "on track" or their negatives or variations and similar terminology and words of similar import generally involve forward-looking statements. These statements reflect the Company's current views with respect to future events and because the Company's business is subject to numerous risks, uncertainties and other factors, the Company's actual results could differ materially from those anticipated in the forward-looking statements. All forward-looking statements rely on a number of assumptions, estimates and data concerning future results and events and that are subject to a number of uncertainties, assumptions and other factors, many of which are outside Aspen's control that could cause actual results to differ materially from such forward-looking statements. Accordingly, there are important factors that could cause our actual results to differ materially from those anticipated in the forward-looking statements, including, but not limited to, our exposure to weather-related natural disasters and other catastrophes, the direct and indirect impact of global climate change, our relationship with, and reliance upon, a limited number of brokers for both our insurance and reinsurance business, the impact of inflation, our exposure to credit, currency, interest and other risks within our investment portfolio, our ability to maintain the listing of our Class A ordinary shares on the New York Stock Exchange or another national securities exchange, the impact of compliance obligations with applicable laws, rules and regulations related to being a public company, the cyclical nature of the insurance and reinsurance industry and many other factors. For a detailed description of these uncertainties and other factors that could impact the forward-looking statements in this press release and other communications issued by or on behalf of Aspen, please see the "Risk Factors" section in Aspen's Annual Report on Form 20-F for the year ended December 31, 2024, as filed with the U.S. Securities and Exchange Commission. The inclusion of forward-looking statements in this press release or any other communication should not be considered as a representation by Aspen that current plans or expectations will be achieved. Aspen undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law. View source version on Contacts Media Jo ScottHead of Corporate +44 20 7184 8000
Business Wire
10-06-2025
- Business
- Business Wire
Aspen Prices Public Offering of US$300,000,000 of Senior Notes
HAMILTON, Bermuda--(BUSINESS WIRE)--Aspen Insurance Holdings Limited ('Aspen' or the 'Company') (NYSE: AHL) has priced an underwritten public offering of US$300,000,000 aggregate principal amount of 5.750% senior notes due 2030 (the 'Notes'). The Notes were priced at 99.870% of the principal amount and will mature on July 1, 2030. The offering was made pursuant to an effective shelf registration statement and is expected to close on June 13, 2025, subject to the satisfaction of customary closing conditions. Aspen intends to use the net proceeds from the offering, together with cash on hand, to repay the indebtedness outstanding under its term loan credit agreement. The offering was led by Citigroup Global Markets Inc., HSBC Securities (USA) Inc. and Lloyds Securities Inc., as joint book-running managers. This offering may be made only by means of a preliminary prospectus supplement and accompanying prospectus. Copies of the final prospectus and accompanying prospectus may be obtained, when available, from the U.S. Securities and Exchange Commission's website at Alternatively, these documents are available from the underwriters by contacting any of the following: Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by calling: (800) 831-9146 or by emailing prospectus@ HSBC Securities (USA) Inc., 66 Hudson Boulevard, New York, NY 10001, Attention: Debt Capital Markets or by calling (866) 811-8049; or Lloyds Securities Inc., 1095 Avenue of the Americas, 34th Floor, New York, New York 10036, by calling (212) 930-5039, or by emailing NALSIBondSyndicate@ This press release shall not constitute an offer to sell or a solicitation of an offer to buy the Notes, nor shall there be any sale of the Notes in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Aspen Insurance Holdings Limited Aspen provides insurance and reinsurance coverage to clients in various domestic and global markets through wholly-owned operating subsidiaries in Bermuda, the United States and the United Kingdom, as well as its branch operations in Canada, Singapore and Switzerland. Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, which include, but are not limited to, statements related to the Company's expectations regarding the use of the net proceeds from the offering, and are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts. In particular, statements that use the words such as 'believe,' 'anticipate,' 'expect,' 'assume,' 'objective,' 'target,' 'plan,' 'estimate,' 'project,' 'seek,' 'will,' 'may,' 'aim,' 'likely,' 'continue,' 'intend,' 'guidance,' 'outlook,' 'trends,' 'future,' 'could,' 'would,' 'should,' 'target,' 'predict,' 'potential,' 'on track' or their negatives or variations and similar terminology and words of similar import generally involve forward-looking statements. These statements reflect the Company's current views with respect to future events and because the Company's business is subject to numerous risks, uncertainties and other factors, the Company's actual results could differ materially from those anticipated in the forward-looking statements. All forward-looking statements rely on a number of assumptions, estimates and data concerning future results and events and that are subject to a number of uncertainties, assumptions and other factors, many of which are outside Aspen's control that could cause actual results to differ materially from such forward-looking statements. Accordingly, there are important factors that could cause our actual results to differ materially from those anticipated in the forward-looking statements, including, but not limited to, our exposure to weather-related natural disasters and other catastrophes, the direct and indirect impact of global climate change, our relationship with, and reliance upon, a limited number of brokers for both our insurance and reinsurance business, the impact of inflation, our exposure to credit, currency, interest and other risks within our investment portfolio, our ability to maintain the listing of our Class A ordinary shares on the New York Stock Exchange or another national securities exchange, the impact of compliance obligations with applicable laws, rules and regulations related to being a public company, the cyclical nature of the insurance and reinsurance industry and many other factors. For a detailed description of these uncertainties and other factors that could impact the forward-looking statements in this press release and other communications issued by or on behalf of Aspen, please see the 'Risk Factors' section in Aspen's Annual Report on Form 20-F for the year ended December 31, 2024, as filed with the U.S. Securities and Exchange Commission. The inclusion of forward-looking statements in this press release or any other communication should not be considered as a representation by Aspen that current plans or expectations will be achieved. Aspen undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law.
Toronto Star
04-06-2025
- Business
- Toronto Star
Check-Cap claims BMO's Chris Taves Illegally Attacks Israeli NASDAQ-Listed Company During Wartime
Check-Cap Ltd. Issues Strong Condemnation of MediPharm Labs Chairman Chris Taves for Fabricated Defamatory Statements Press Releases Taves Times his Attack to Commence 23 Minutes before the Start of Shabbat to Delay the Company from Responding ISFIYA, ISRAEL, June 04, 2025 (GLOBE NEWSWIRE) — Check-Cap Ltd. (NASDAQ: CHEK) ('Check-Cap' or the 'Company'), a clinical-stage medical diagnostics company incorporated in Israel, today publicly condemned MediPharm Labs Corp. (LABS) ('MediPharm Labs') and its Chairman, Chris Taves, Head of Asia for BMO Capital Markets, for disseminating derogatory, false, and misleading statements about Check-Cap during a profoundly sensitive and challenging time for Israeli Companies. ARTICLE CONTINUES BELOW Check-Cap is deeply disturbed that Mr. Taves would leverage the implied authority of his position as a senior BMO Executive to exploit the wartime circumstances currently affecting Israel, in order to knowingly spread false information aimed at harming Check-Cap's reputation, stock price, and business relationships. This conduct is not only unethical and unlawful - it is shameful. Specifically, MediPharm Labs's May 23, 2025 press release quoted Mr. Taves making what Check Cap believes to be demonstrably false statements about Check-Cap. Even more egregious, Mr. Taves, a financial executive who surely knows better, publicly disseminated his accusation of there being deficiencies in our public disclosures, without any actual factual basis whatsoever. Check-Cap believes that Mr. Taves is misusing his position of trust as a BMO Capital Markets Executive to intentionally issue these misleading statements during trading hours in order to manipulate and drive down Check-Cap's stock price, violating Section 9(a)(2) of the U.S. Securities Exchange Act of 1934. Check-Cap demands that MediPharm Labs and Mr. Taves immediately retract the defamatory press release, cease all related misleading communications, and publicly apologize for Mr. Taves disgraceful actions. The fact that Mr. Taves and MediPharm Labs have chosen to launch such deplorable and unfounded attacks on an Israeli company minutes before the start of Shabbat at a time of war is reprehensible. Check-Cap will vigorously defend its reputation and its rights against these highly unethical attempts at aspersion, market manipulation and interference in a public transaction. About Check-Cap Check-Cap (NASDAQ: CHEK) is a clinical stage medical diagnostics company aiming to redefine colorectal cancer (CRC) screening through the introduction of C-Scan®, the first and only patient-friendly preparation-free screening test to detect polyps before they may transform into colorectal cancer and enable early intervention and cancer prevention. C-Scan is an investigational device and is not available for sale in the United States. ARTICLE CONTINUES BELOW ARTICLE CONTINUES BELOW Legal Notice Regarding Forward-Looking Statements This press release contains 'forward-looking statements' about the Company's expectations, beliefs or intentions regarding, among other things, its product development efforts, business, financial condition, results of operations, strategies or prospects. Words such as 'may,' 'should,' 'could,' 'would,' 'predicts,' 'potential,' 'continue,' 'expects,' 'anticipates,' 'future,' 'intends,' 'plans,' 'believes,' 'estimates,' and similar expressions, as well as statements in future tense, often signify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and may not be accurate indications of when such performance or results will be achieved. Forward-looking statements are based on information that the Company has when those statements are made or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. For a discussion of these and other risks that could cause such differences and that may affect the realization of forward-looking statements, please refer to the 'Forward-looking Statements' and 'Risk Factors' in the Company's Annual Report on Form 20-F for the year endedDecember 31, 2023and other filings with the Securities and Exchange Commission (SEC). Investors and security holders are urged to read these documents free of charge on the SEC's web site at The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise. info@
